Authors


Joely Kaufman, MD

Latest:

Periorbital Rejuvenation: Comprehensive Assessment and Product Choice Are Key to Results

With a wide range of aesthetic options available, clinicians can create a personalized approach to addressing age-related changes around the eye to give patients the natural-looking results they desire.


Leslie Baumann, M.D.

Latest:

New column will simplify laser choices, use

Are you confused about lasers? Are you afraid to admit that you don't know the difference between "Q- switched" and "pulsed dye"? You are not alone and we are here to help "shed the light" on the confusing array of lasers and light devices.


Norman Levine, M.D.

Latest:

When is the right time to retire?

Norman Levine, M.D., discusses the potential benefits and pitfalls of retiring from dermatology.


Robert C. Silkey

Latest:

Know elements for Web site success

Security is the most critical component. Does the e-mail package you're considering meet the 2005 HIPAA guidelines for patient privacy and security? And does the hosting company have the ability to safely share files between two or three offices?


Barbara Boughton

Latest:

Investigating unusual facial hyperpigmentation in darker skin

The hyperpigmentation, in contrast to melasma, often had blurry or ill-defined borders that seemed to fade into the patient's skin color.


Elizabeth Woodcock, MBA, FACMPE, CPC

Latest:

What's your Web site doing for you?

As more consumers hop onto the World Wide Web to search for information about healthcare, it's simply a must for dermatology practices to have Web sites.


Vic A. Narurkar, M.D.

Latest:

The right tool: Lesion type determines which laser, light device is best choice

Hyperpigmented lesions come in many varieties. Etiologies vary from sun exposure to trauma to inflammation, and even idiopathic origins.


Helen Torok, MD

Latest:

Editorial Advisory Board Insights for Eczema Awareness Month: Helen Torok, MD

Helen Torok, MD, shares her atopic dermatitis insights.


Corinna S. Bowser, MD

Latest:

Sulfasalazine, dapsone: Good alternative options for treatment of chronic urticaria

Philadelphia - In patients with chronic urticaria who do not respond to standard antihistamine treatment, the older drugs sulfasalazine and dapsone represent promising new treatment alternatives, Lisa A. Beck, M.D. said here at the 2006 meeting of the American College of Allergy, Asthma & Immunology (ACAAI).


James Turner, M.D., Ph.D.

Latest:

Effectively managing GIF in the psoriasis patient

GIF typically manifests during the first six to 10 weeks of treatment, and affects existing plaques with or without the presence of new lesions.


Tim Troy

Latest:

Etanercept presents as quick Tx

National Report -- A study reported in a recent edition of the New England Journal of Medicine indicates people with moderate to severe plaque psoriasis treated with etanercept experienced significant clearing of skin lesions within the first two weeks of taking the medication.


Steven Emmet, M.D.

Latest:

Tech breakthroughs

Dial-up modems, which opened the Internet to a vast audience and are still commonly found in medical offices, nominally create a 56k connection, although it is often closer to 44k and, depending on your line quality, 28k. With the prodigious amount of spam and viruses being circulated these days, it can often take 30 minutes or more just to download an e-mail, and if my colleagues have sent large picture files, it could take 45 minutes or more.


Indra Neal Sinha

Latest:

Experimental therapy figures to save limbs

Cambridge, Mass. - An experimental therapy that makes use of fibroblast growth factor type 1 (FGF-1) encoded in naked plasmid DNA (NV1FGF) could save the limbs of patients afflicted with chronic wounds due to critical leg ischemia associated with peripheral arterial disease (PAD), according to Vincent Li, M.D., M.B.A.


John Kelly C.L.U., R.H.U.

Latest:

What's new in retirement planning?

Defined benefit pension plans as well as cash balance plans are generating a lot of interest with medical practices, both large and small.


David B. Mandell, J.D., M.B.A.

Latest:

Do You Have the Right Financial Adviser?

Experts detail 5 tips to ask a financial advisor so they can best serve your interests.


Christopher R. Jarvis, M.B.A.

Latest:

Four money-saving ideas can help you prepare for Tax Day 2010

As a physician, do you realize that, between income, capital gains, Medicare, self-employment and other taxes, you spend 40 percent to 50 percent of your working hours laboring for the IRS and your state?


Ilya Petrou M.D.

Latest:

New devices modify noninvasive skin tightening

Approximately 94 percent of patients treated with the multiple pass/low fluence algorithm showed visible skin tightening at the time of treatment.


David B. Mandell, JD, MBA

Latest:

Protecting Against Malpractice Liability: Insurance As Your First Line of Defense

David Mandell, JD, MBA, stated in the quest to protect against malpractice liability, insurance is certainly the first and most important line of defense.


Elizabeth W. Woodcock, MBA, FACMPE, CPC

Latest:

Reducing no-shows

Starting Oct. 1, 2007, the Centers for Medicare and Medicaid Services (CMS) officially endorsed the practice of physicians charging a fee to Medicare beneficiaries who fail to show up for appointments. If you charge Medicare patients a fee for missing appointments, however, you must charge the same fee to all who skip appointments, regardless of the payer.


Robert A. Ersek

Latest:

Surgeon shares rationale for lip on 12-year-old

The circumstances around this case are quite unusual, but the bottom line is that I had been called upon to justify my position of doing liposuction and an abdominoplasty on a youngster.


Michael Halloran, MBA, CFP

Latest:

Living in a Litigious World Demands Defensive Asset Protection

In today's society, the lawsuit is seen as a way to "get rich quick" rather than as a method of creating justice.


Karen Donley-Hayes

Latest:

Reaching for a retinoid? Less may be more

Washington - Adapalene 0.1 percent gel is similar in efficacy against acne, with fewer side effects, than either tazarotene 0.1 percent or a regimen in which patients were switched from one retinoid to the other after six weeks.


Lisa B. Samalonis

Latest:

Pediatric dermatoses: Off-label biologic use carries risks, benefits

Psoriasis in adults is among the most-researched inflammatory skin diseases. Yet treatment options for moderate-to-severe atopic dermatitis and psoriasis in children represents a largely unmet medical need, according to an expert.


Patty Reiman

Latest:

Light intensifier: LED combo treats rosacea erythema

Combining LED therapy with laser or intense pulsed light can effectively treat rosacea and subsequent erythema, an expert says.


Ilya Petrou, M.D.

Latest:

Study finds HS associated with acne conglobata

Hidradenitis suppurativa has come to be associated with systemic inflammation as well as a growing list of comorbidities including acne conglobate.


Lisa Samalonis

Latest:

Polycystic ovary syndrome treatment requires holistic approach

For young women with polycystic ovary syndrome (PCOS), dermatologists must diagnose the underlying hormonal issues to best treat the related skin symptoms, explains Helen M. Torok, M.D., medical director, Trillium Creek Dermatology & Surgery, Medina, Ohio.


Michelle Tackla

Latest:

Beautiful Minds?

Leading sources suggest that cosmetic surgeons should carefully monitor the psychological condition and ambitions of existing and potential cosmetic patients despite a recent study finding that aesthetic procedures significantly improve a patient's quality of life.


Mark G. Lebwohl, MD

Latest:

Key Takeaways For the Management of Plaque Psoriasis

Experts in dermatology share closing thoughts on the management of plaque psoriasis.


Steven Feldman, MD, PhD

Latest:

Long-term Safety and Tolerability Experience with TNF Inhibitors

The class of agents known as TNF inhibitors shares some common safety issues, but the safety profiles of specific agents vary due to differing characteristics and mechanisms. Comparing safety data of these drugs is, of course, complicated by differences in patient populations and experiences.


Alice B. Gottlieb, MD, PhD

Latest:

Alice Gottlieb, MD, PhD: Preventing Pain and Disability in Psoriatic Disease

Gottlieb reviews her lecture from the Society for Investigative Dermatology Annual Meeting.

© 2025 MJH Life Sciences

All rights reserved.